HOUSE DOCKET, NO. 1281        FILED ON: 1/14/2025

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No.         

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Michael S. Chaisson

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to law enforcement access to prescription monitoring data.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

Michael S. Chaisson

1st Bristol

1/8/2025


HOUSE DOCKET, NO. 1281        FILED ON: 1/14/2025

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No.         

[Pin Slip]

 

[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE HOUSE, NO. 1394 OF 2023-2024.]

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninety-Fourth General Court
(2025-2026)

_______________

 

An Act relative to law enforcement access to prescription monitoring data.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Clause (4) of subsection (f) of Section 24A of Chapter 94C of the General Laws, as appearing in the 2022 Official Edition, is hereby amended by striking out the words “and accompanied by a probable cause warrant issued pursuant to chapter 276”.

SECTION 2. Said subsection (f) of said Section 24A of said Chapter 94C is hereby further amended by striking out clause (6), as appearing in the 2022 Official Edition, and inserting in place thereof the following clause:-

(6) personnel of: (A) the United States attorney or a federal agency; provided, however, that the data request is made pursuant to clause (4) or federal law; (B) the office of the attorney general provided, however, that the data request is in connection with a bona fide specific controlled substance or additional drug-related investigation; or (C) a district attorney’s office; provided, however, that the data request is in connection with a bona fide specific controlled substance or additional drug-related investigation;